title: International Myeloma Working Group recommendations for global myeloma care.
abstract: Recent developments have led to remarkable improvements in the assessment and treatment of patients with multiple myeloma (MM). New technologies have become available to precisely evaluate the biology and extent of the disease, including information about cytogenetics and genetic abnormalities, extramedullary manifestations and minimal residual disease. New, more effective drugs have been introduced into clinical practice, which enable clinicians to significantly improve the outcome of patients but also pose new challenges for the prevention and management of their specific side effects. Given these various new options and challenges, it is important to identify the minimal requirements for diagnosis and treatment of patients, as access to the most sophisticated advances may vary depending on local circumstances. Here, we propose the minimal requirements and possible options for diagnosis, monitoring and treatment of patients with multiple myeloma.
authors.affiliation: Department of Medicine I, Center of Oncology, Hematology and Palliative Care, Wilhelminenspital, Vienna, Austria.
authors.forename: H
authors.initials: H
authors.lastname: Ludwig
authors.affiliation: Clinica Universidad de Navarra, Pamplona, Spain.
authors.forename: J S
authors.initials: JS
authors.lastname: Miguel
authors.affiliation: Department of Clinical Therapeutics, University of Athens, School of Medicine, Athens, Greece.
authors.forename: M A
authors.initials: MA
authors.lastname: Dimopoulos
authors.affiliation: Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Palumbo
authors.affiliation: Servicio de Hematologia, Hospital Universitario de Salamanca, Salamanca, Spain.
authors.forename: R
authors.initials: R
authors.lastname: Garcia Sanz
authors.affiliation: Parkside Cancer Centre, London, UK.
authors.forename: R
authors.initials: R
authors.lastname: Powles
authors.affiliation: Columbia University Medical Center, New York, NY, USA.
authors.forename: S
authors.initials: S
authors.lastname: Lentzsch
authors.affiliation: Chaoyang Hospital, Capital Medical University, Beijing, China.
authors.forename: W
authors.initials: W
authors.lastname: Ming Chen
authors.affiliation: Shanghai Chang Zheng Hospital, Shanghai, China.
authors.forename: J
authors.initials: J
authors.lastname: Hou
authors.affiliation: Department of Hematology, University Hospital, Cracow, Poland.
authors.forename: A
authors.initials: A
authors.lastname: Jurczyszyn
authors.affiliation: Haematology Department, Wellington Hospital, Wellington, New Zealand.
authors.forename: K
authors.initials: K
authors.lastname: Romeril
authors.affiliation: Department of Internal Medicine, University of Ostrava, Ostrava, Czech Republic.
authors.forename: R
authors.initials: R
authors.lastname: Hajek
authors.affiliation: Department of Clinical Therapeutics, University of Athens, School of Medicine, Athens, Greece.
authors.forename: E
authors.initials: E
authors.lastname: Terpos
authors.affiliation: Nagoya City Midori General Hospital, Nagoya, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Shimizu
authors.affiliation: Institute of Hematology, Royal Prince Alfred Hospital, Sydney, Australia.
authors.forename: D
authors.initials: D
authors.lastname: Joshua
authors.affiliation: Santa Casa de Sao Paulo, Sao Paolo, Brazil.
authors.forename: V
authors.initials: V
authors.lastname: Hungria
authors.affiliation: Bonco Metro Politano de Sangre, Caracas, Venezuela.
authors.forename: A
authors.initials: A
authors.lastname: Rodriguez Morales
authors.affiliation: Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
authors.forename: D
authors.initials: D
authors.lastname: Ben-Yehuda
authors.affiliation: University of Giessen, Giessen, Germany.
authors.forename: P
authors.initials: P
authors.lastname: Sondergeld
authors.affiliation: Istituto di Ematologia Seràgnoli, Università degli Studi di Bologna, Bologna, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Zamagni
authors.affiliation: Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA, USA.
authors.forename: B
authors.initials: B
authors.lastname: Durie
mesh_terms: D006801:Humans; D008991:Monitoring, Physiologic; D009101:Multiple Myeloma / Q000503:physiopathology / Q000628:therapy*; D012008:Recurrence; D016896:Treatment Outcome